OTV (formerly known as Olive Tree Ventures), an Israel-based digital health first venture capital firm, closed a fund, at $170M.
Founded in 2015 by General Partners Mayer Gniwisch, Amir Lahat and Alejandro Weinstein, OTV has a primary focus on digital health, specializing in helping their portfolio companies reach maturity, refine execution, tackle regulatory hurdles and ensure a global imprint on validated products.
Over the course of the past five years, the firm has prioritized investment in digital health companies that develop innovative solutions to today’s most pressing healthcare problems. The portfolio includes TytoCare, Lemonaid Health, Emedgene, Scopio and Donisi Health.
The firm, whose team also includes Partner Manor Zemer, has appointed Jose Antonio Urrutia Rivas as Head of Asia Pacific. Urrutia Rivas is a graduate of the China Europe International Business School in Shanghai’s MBA program, and previously worked at LarrainVial as the Asian Market developer. Equipped with a wealth of experience in the region, he will manage OTV’s new Asia Pacific office, based in China. The new office will complement existing branches in New York, Tel Aviv and Montreal, and will offer portfolio companies the opportunity to expand in a region where the digital health field is robust and well-developed.